• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

商业保险覆盖的慢性阻塞性肺疾病患者的自付费用和处方配药行为。

Out-of-Pocket Costs and Prescription Filling Behavior of Commercially Insured Individuals With Chronic Obstructive Pulmonary Disease.

机构信息

IQVIA, Cambridge, Massachusetts.

Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.

出版信息

JAMA Health Forum. 2022 May 27;3(5):e221167. doi: 10.1001/jamahealthforum.2022.1167. eCollection 2022 May.

DOI:10.1001/jamahealthforum.2022.1167
PMID:35977254
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9142864/
Abstract

This cohort study uses a longitudinal access and adjudication data set to evaluate prescription out-of-pocket costs and filling behaviors of commercially insured individuals with chronic obstructive pulmonary disease (COPD).

摘要

这项队列研究使用纵向获取和裁决数据集，评估了商业保险的慢性阻塞性肺疾病（COPD）患者的处方自付费用和用药行为。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87a1/9142864/512c09cbec7d/jamahealthforum-e221167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87a1/9142864/512c09cbec7d/jamahealthforum-e221167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87a1/9142864/512c09cbec7d/jamahealthforum-e221167-g001.jpg

相似文献

1
Out-of-Pocket Costs and Prescription Filling Behavior of Commercially Insured Individuals With Chronic Obstructive Pulmonary Disease.商业保险覆盖的慢性阻塞性肺疾病患者的自付费用和处方配药行为。
JAMA Health Forum. 2022 May 27;3(5):e221167. doi: 10.1001/jamahealthforum.2022.1167. eCollection 2022 May.
2
Direct costs of chronic obstructive pulmonary disease among managed care patients.管理式医疗患者慢性阻塞性肺疾病的直接成本。
Int J Chron Obstruct Pulmon Dis. 2010 Oct 5;5:341-9. doi: 10.2147/COPD.S13771.
3
Time to Filling of New Prescriptions for Chronic Disease Medications Among a Cohort of Elderly Patients in the USA.美国老年患者队列中新开慢性病药物处方的时间。
J Gen Intern Med. 2018 Nov;33(11):1877-1884. doi: 10.1007/s11606-018-4592-6. Epub 2018 Jul 27.
4
Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis.解释老年医疗保险受益人群中患有慢性阻塞性肺病的患者中胃食管反流病相关医疗费用增加的原因：成本分解分析。
Int J Chron Obstruct Pulmon Dis. 2014 Apr 8;9:339-48. doi: 10.2147/COPD.S59139. eCollection 2014.
5
High-Deductible Health Plans and Healthcare Access, Use, and Financial Strain in Those with Chronic Obstructive Pulmonary Disease.高自付额健康计划与慢性阻塞性肺疾病患者的医疗保健获取、使用和经济负担
Ann Am Thorac Soc. 2020 Jan;17(1):49-56. doi: 10.1513/AnnalsATS.201905-400OC.
6
Health-care utilization and expenditures among patients with comorbid bronchiectasis and chronic obstructive pulmonary disease in US clinical practice.支气管扩张症合并慢性阻塞性肺疾病患者在美国临床实践中的医疗保健利用和支出。
Chron Respir Dis. 2019 Jan-Dec;16:1479973119839961. doi: 10.1177/1479973119839961.
7
Out-of-pocket costs for commercially insured patients with localized prostate cancer.商业保险患者前列腺癌局部治疗的自付费用。
Urol Oncol. 2021 Dec;39(12):797-805. doi: 10.1016/j.urolonc.2021.08.026. Epub 2021 Sep 30.
8
Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps.美国肿瘤学均等法案下有和无自付费用上限对癌症药物使用和支出的比较。
JAMA Health Forum. 2021 May 28;2(5):e210673. doi: 10.1001/jamahealthforum.2021.0673. eCollection 2021 May.
9
What is the cost to employers of direct medical care for chronic obstructive pulmonary disease?雇主为慢性阻塞性肺疾病提供直接医疗护理的成本是多少？
COPD. 2006 Dec;3(4):203-9. doi: 10.1080/15412550600977320.
10
Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.与异丙托溴铵相比，使用丙酸氟替卡松500微克/沙美特罗50微克进行初始维持治疗的老年人慢性阻塞性肺疾病住院/急诊就诊风险及治疗费用。
Am J Geriatr Pharmacother. 2008 Aug;6(3):138-46. doi: 10.1016/j.amjopharm.2008.08.005.

引用本文的文献

1
Patenting Strategies on Inhaler Delivery Devices.吸入器给药装置的专利策略。
Chest. 2023 Aug;164(2):450-460. doi: 10.1016/j.chest.2023.02.031. Epub 2023 Feb 25.
2
Manufacturer Revenue on Inhalers After Expiration of Primary Patents, 2000-2021.2000 - 2021年主要专利到期后吸入器的制造商收入
JAMA. 2023 Jan 3;329(1):87-89. doi: 10.1001/jama.2022.19691.

本文引用的文献

1
Mapping geographic variability of severe uncontrolled asthma in the United States: Management implications.美国严重未控制哮喘的地理变异情况绘图：管理启示。
Ann Allergy Asthma Immunol. 2022 Jan;128(1):78-88. doi: 10.1016/j.anai.2021.09.025. Epub 2021 Oct 7.
2
Association of Nonmedical Switches in Inhaled Respiratory Medications with Disruptions in Care: A Retrospective Prescription Claims Database Analysis.吸入式呼吸药物中的非医疗转换与护理中断的关联：一项回顾性处方索赔数据库分析。
Pulm Ther. 2021 Jun;7(1):189-201. doi: 10.1007/s41030-021-00147-8. Epub 2021 Mar 12.
3
Prevalence and Persistence of Cost-Related Medication Nonadherence Among Medicare Beneficiaries at High Risk of Hospitalization.
住院高风险医疗保险受益人中与费用相关的药物治疗不依从的患病率和持续性
JAMA Netw Open. 2021 Mar 1;4(3):e210498. doi: 10.1001/jamanetworkopen.2021.0498.
4
Asthma-chronic obstructive pulmonary disease overlap and cost-related medication non-adherence among older adults in the United States.美国老年人中哮喘-慢性阻塞性肺疾病重叠和与费用相关的药物不依从性。
J Asthma. 2022 Mar;59(3):484-493. doi: 10.1080/02770903.2020.1868497. Epub 2021 Jan 19.
5
Clinical outcomes associated with pathogenic genomic instability mutations in prostate cancer: a retrospective analysis of US pharmacy and medical claims data.与前列腺癌致病性基因组不稳定性突变相关的临床结局：对美国药房和医疗索赔数据的回顾性分析。
J Med Econ. 2019 Oct;22(10):1080-1087. doi: 10.1080/13696998.2019.1649267. Epub 2019 Aug 28.